• Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase

  • Jan 23 2025
  • Duración: 1 m
  • Podcast

Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack.

    Molly O’Brien has the details in this Migraine Minute News Update.


    Read More: https://bit.ly/3BY2J9d
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles